SOCS6 is a selective suppressor of receptor tyrosine kinase signaling

Nuzhat N Kabir1, Jianmin Sun, Lars Rönnstrand

  • 1Laboratory of Computational Biochemistry, KN Biomedical Research Institute, Barisal, Bangladesh.

Insights

Suppressors of cytokine signaling 6 (SOCS6) negatively regulates receptor tyrosine kinase signaling by promoting protein degradation and apoptosis. SOCS6 downregulation in cancers highlights its role in survival signaling.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Signaling

Background:

  • Suppressors of cytokine signaling (SOCS) proteins are key negative regulators of cytokine receptor signaling.
  • SOCS6, a member of the SOCS family, uniquely targets receptor tyrosine kinase signaling pathways.
  • SOCS6 protein structure includes an N-terminal region, SH2 domain, and SOCS box.

Purpose of the Study:

  • To elucidate the specific role of SOCS6 in receptor tyrosine kinase signaling.
  • To investigate the mechanisms by which SOCS6 regulates cell survival and apoptosis.
  • To examine the implications of SOCS6 downregulation in various human cancers.

Main Methods:

  • Analysis of SOCS6 expression patterns in different tissues and cancer types.
  • Investigation of SOCS6's role in protein ubiquitination and degradation pathways.
  • Assessment of SOCS6's impact on apoptosis induction via mitochondrial pathways.

Main Results:

  • SOCS6 is widely expressed but downregulated in numerous cancers, including colorectal, gastric, and lung cancer.
  • SOCS6 mediates negative regulation of receptor signaling through enhanced ubiquitination and degradation of receptors and substrates.
  • SOCS6 induces apoptosis by targeting mitochondrial proteins, thus acting as a regulator of survival signaling.

Conclusions:

  • SOCS6 is a critical negative regulator of receptor tyrosine kinase signaling.
  • SOCS6's tumor-suppressive activity is linked to its role in promoting protein degradation and apoptosis.
  • Restoring SOCS6 activity may offer therapeutic potential for various cancers characterized by its downregulation.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.1K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.0K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.4K